The expansion includes growing the lab’s immunochemistry and biomarker space by 8,000 square feet
PPD anticipates adding approximately 200 new positions as a result of its continuing expansion at the bioanalytical lab
Work also is scheduled to begin this month to create a 4,500-square-foot cell lab
PPD plans to add 30,000 square feet of space dedicated to chromatography services
PPD's Richmond bioanalytical lab provides services such as small molecule, biologics, vaccines and biomarker testing capabilities
PPD to design and build a facility focusing on modern mass spectrometry and automation and offering a layout optimized for the bioanalysis of complex molecules, such as antibody-drug conjugates, and cell and gene therapies
“The ongoing expansion of our bioanalytical lab – coupled with previous enhancements to our biologics capabilities – builds on the growth of our drug development expertise over the past three decades to the point that we now support pharmaceutical programs from preclinical through post-approval,” said Christopher Fikry, M.D., executive vice president of PPD Laboratories